400-6699-1171000

分析测试百科网 认证会员,请放心拨打!

首页> 产品展示> RO5126766 (CH5126766),946128-88-7,10mM in DMSO
高级会员

诚信认证:

工商注册信息已核实!

产品分类
微信二维码
QQ号咨询

点击这里给上海阿拉丁生化科技股份有限公司

抑制剂

RO5126766 (CH5126766),946128-88-7,10mM in DMSO

英文名称:RO5126766 (CH5126766)
品牌 厂商性质 产地 货期
阿拉丁 总代理 中国 现货

性能特点

InformationRO5126766 (CH5126766, VS 6766, CKI-27, R-7304, RG-7304) is a dualRAF/MEKinhibitor wit

在线咨询 询底价
AI问答
配套的仪器设备? 可以搭配的相关耗材试剂?
产品参数
货号 规格 CAS号 价格 操作
R427048-1ml 1ml 946128-88-7 ¥720.90 询底价
产品介绍

中文名:RO5126766 (CH5126766)

英文名:RO5126766 (CH5126766)

英文别名:946128-88-7|RO5126766|avutometinib|CH5126766|RO-5126766|RO-5126766 free base|Ro 5126766|CH-5126766|RO5126766(CH5126766)|RG-7304|VS-6766|CKI-27|3-[[2-[(methylaminosulfonyl)amino]-3-fluoropyridin-4-yl]methyl]-4-methyl-7-[(pyrimidin-2-yl)oxy]-2H-1-benzopyran

纯度:10mM in DMSO

货号:R427048

Cas号:946128-88-7

存储温度:-80℃储存

产品介绍:

Information

RO5126766 (CH5126766, VS 6766, CKI-27, R-7304, RG-7304) is a dualRAF/MEKinhibitor withIC50of 8.2 nM,19 nM, 56 nM, and 160 nM for BRAF V600E, BRAF, CRAF, and MEK1, respectively. Phase 1.

Targets

BRAF V600E (cell-free assay); BRAF (cell-free assay); CRAF (cell-free assay); MEK1 (cell-free assay) 8.2 nM; 19 nM; 56 nM; 160 nM

In vitro

In HCT116 KRAS-mutant colorectal cancer cells, CH5126766 significantly reduces the levels of phospho-MEK and phospho-ERK. CH5126766 inhibits RAF kinase by binding to MEK1, and causes MEK to become a dominant negative inhibitor of RAF. In Raf or RAS-mutant cell lines SK-MEL-28, SK-MEL-2, MIAPaCa-2, SW480, HCT116, and PC3 cells, CH5126766 inhibits cell growth with IC50 of 65, 28, 40, 46, and 277 nM, respectively. In two melanoma cell lines with the BRAF V600E or NRAS mutation, RO5126766 induces G1 cell cycle arrest accompanied by up-regulation of the CDK inhibitor p27 and down-regulation of cyclinD1.

In vivo

In an HCT116 (G13D KRAS) mouse xenograft model, CH5126766 (25 mg/kg, p.o.) inhibits ERK signaling output more effectively than a standard MEK inhibitor that induces MEK phosphorylation and has potent antitumor activity. In the HCT116 (K-ras) and COLO205 (B-raf) mutant xenografts, CH5126766 (0.3 mg/kg) causes significant decreases in [18\u2009F]FDG uptake. In the SK-MEL-2 xenograft model, RO5126766 also suppresses the tumor growth.

Cell Research(from reference)

Cell lines:SK-MEL-28, SK-MEL-2, MIAPaCa-2, SW480, A549, HCT15, HCT116, and PC3 cells 

Concentrations:~10 μM 

Incubation Time:72 h 


查看阿拉丁官网此产品相关对应页面:https://www.aladdin-e.com/zh_cn/R427048.html


RO5126766 (CH5126766),946128-88-7,10mM in DMSO信息由上海阿拉丁生化科技股份有限公司为您提供,如您想了解更多关于RO5126766 (CH5126766),946128-88-7,10mM in DMSO报价、型号、参数等信息,欢迎来电或留言咨询。

注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途

店铺推荐
  • 品牌:阿拉丁
    FRAX 486,PAK抑制剂,1232030-35-1,96%

    FRAX 486,PAK抑制剂,1232030-35-1,96%

    询价
  • 品牌:阿拉丁
    3,3',4,5'-四甲氧基白皮杉醇,83088-26-0,98%

    3,3',4,5'-四甲氧基白皮杉醇,83088-26-0,98%

    询价
  • 品牌:阿拉丁
    穿心莲内酯,5508-58-7,分析标准品

    穿心莲内酯,5508-58-7,分析标准品

    询价
  • 品牌:阿拉丁
    芹菜素,520-36-5,分析标准品,≥98%

    芹菜素,520-36-5,分析标准品,≥98%

    询价
  • 品牌:阿拉丁
    (+)-蒜氨酸,556-27-4,分析标准品,98%

    (+)-蒜氨酸,556-27-4,分析标准品,98%

    询价
  • 品牌:阿拉丁
    宝藿苷I,113558-15-9,分析标准品

    宝藿苷I,113558-15-9,分析标准品

    询价